Literatur
Bennett RT, Lerner SE, Taub HC, Dutcher JP, Fleischmann J (1995) Cytoreductive surgery for stage IV renal cell carcinoma. J Urol 154: 32–34
Bennett BC, Selby R, Bahnson RR (1995) Surgical resection for management of renal cancer with hepatic involvement. J Urol 154: 972–974
Branscheid D, Krysa S, Stoelben E, Bülzebruck H, Probst G, Vogt-Moykopf I (1992) Chirurgische Therapie von Lungenmetastasen beim Nierenzellkarzinom —Diagnostik, Strategie, Ergebnisse. Akt Urol 23: 106–112
Cozzolli A, Milano S, Cancarini G, Zanotelli T, Cunico SC (1995) Surgery of lung metastases in renal cell carcinoma. Br J Urol 75: 445–447
de Riese W, Alloff E, Kirchner H, Stief CG, Atzpodien J, Maschek H, Jonas U (1991) Complete spontaneous regression in metastatic renal cell carcinoma —an update and review. World J Urol 9: 184–191
Dreicer R, Galbraith SS, Davis CS, See WA (1997) Surgical resection of metastatic renal cell carcinoma: University of Iowa experience, J Urol 157 [Suppl]: 67
Fischer C, Wächter W, Miller J, Weidner W, Dudeck J (1997) Urologische Tumoren in Deutschland: Ersterhebungen an 56013 Fällen aus Klinischen Krebsregistern. Urologe [A] 36: 253–255
Herrlinger A, Schrott KM, Sigel A (1991) What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma? J Urol 146: 1224–1227
Johnsen JA, Hellsten S (1997) Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol 157: 450–453
King GJ, Kostuik JP, McBroom RJ, Richardson W (1991) Surgical management of metastatic renal carcinoma of the spine. Spine 16: 265–271
Levy DA, Slaton JW, Ellerhorst J, Swanson DA, Dinney CPN (1997) Feasibility of cytoreductive surgery prior to systemic biologic therapy in carefully selected pT4 RCC. J Urol 157 [Suppl]: 72
Moch H, Casser T, Urrejola C, Sauter G, Torhost J, Mihatsch M (1997) Metastatic behavior of renal cell cancer: an analysis of 871 autopsies. J Urol 157 [Suppl]: 66
Pomer S, Klopp M, Steiner HH, Brkovic D, Staehler G, Cabillin-Engenhart R (1997) Hirnmetastasierung beim Nierenzellkarzinom. Urologe [A] 36: 117–125
Saitoh H (1981) Distant metastasis of renal adenocarcinoma. Cancer 48: 1487–1490
Schabel J (1997) Indikation zur Nephrektomie beim metastasierten Nierenkarzinom. Urologe [B] 37: 466–467
Smith EM, Kursh ED, Makley J, Resnick MI (1992) Treatment of osseous metastases secondary to renal cell carcinoma. J Urol 148: 784–787
Tanguay S, Pisters LL, Lawrence DD, Dinney CPN (1996) Therapy of locally recurrent renal cell carcinoma after nephrectomy. J Urol 155: 26–29
van der Poel HG, Roukema JA, Horenblas S, van Geel AN, Debruyne FMJ (1997) Metastasectomy in renal carcinoma. A multicenter analysis. J Urol 157 [Suppl]: 72
von Eschenbach AC, Avallone A, Price J, Swanson D, Killion J, Stepenhenson R, Fidler IJ (1990) The biology of renal cancer: the influence of nephrectomy. Eur Urol 18 [Suppl 2]: 40–41
Walther CM, Yang JC, Pass HI, Rosenberg StA, Linehan WM (1997) Cytoreductive surgery prior to IL-2 based immunotherapy in patients with metastatic renal cell carcinoma. J Urol 157 [Suppl]: 70
Wronski M, Arbit E, Russo P, Galicich JH (1996) Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology 47: 187–193
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fischer, C. Wann sind operative Maßnahmen beim metastasierten Nierenzellkarzinom sinnvoll?. Der Urologe B 38, S14–S17 (1998). https://doi.org/10.1007/s001310050364
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001310050364